Physician profile
Muhammad Khan
NPI 1720391279
$5,132.19
in general payments reported to CMS, 2019-2025
9 companies · $247 in 2025
The $247 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45.36 · 2021: $125 · 2022: $77.84 · 2023: $2,668 · 2024: $1,968 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,311 · Travel and Lodging: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,311.18 |
| Travel and Lodging | $1,572.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,534.09 | 2022-2025 | Target, Trevo, Surpass Evolve |
| Rapid Medical LTD | $845.14 | 2024 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Imperative Care, INC | $460.24 | 2024-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Biogen, INC. | $176.48 | 2020-2025 | Spinraza |
| Medtronic, INC. | $44.16 | 2022-2023 | Pipeline |
| Alnylam Pharmaceuticals INC. | $25.00 | 2025 | Onpattro |
| Abbvie INC. | $18.35 | 2022 | |
| Assertio Therapeutics, INC. | $14.51 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.